Fig. 5From: Antitumor activity of the protein kinase inhibitor 1-(β-D-2′-deoxyribofuranosyl)-4,5,6,7-tetrabromo- 1H-benzimidazole in breast cancer cell linesWestern blot analysis of proteins in whole cell extracts obtained from cells cultured in the presence of K164 (concentrations of 10 μM, 20 μM, and 50 μM) after 48 h of incubation. Preparation of cell extracts and protein detection are described in Materials and Methods. Densitometry analysis was used to quantify all bands, and their intensity was normalized with respect to β-actin. For cell lines cultured in the absence of K164, the ratio of the examined proteins to β-actin was assumed to be 1. Panel A: PARP, AKT1, p 53, and B-cell lymphoma 2 (BCL-2) family proteins (pro- and anti- apoptotic). Panel B: phosphorylated proteinsBack to article page